Clinical genetic analysis of Parkinson's disease in the Contursi kindred

Annals of Neurology
L I GolbeR C Duvoisin

Abstract

We performed a clinical genetic analysis of a kindred originating in the town of Contursi in Salerno province, Italy, in which 60 individuals in 5 generations are known to have had Parkinson's disease (PD). Two previously reported autopsy cases showed typical PD with Lewy bodies. The inheritance pattern is apparently autosomally dominant with a segregation ratio of 40.1% for kindred members aged 50 years and older. The mean age at PD onset is 45.6 years (standard deviation, 13.48; range, 20-85) with a mean course to death of 9.2 years (standard deviation, 4.87; range, 2-20). Otherwise, clinical characteristics of PD in the kindred, including variance in onset age and incidence of tremor and levodopa responsiveness, are similar to those of PD in the community. The presence of tremor tended to be concordant in affected parent-child pairs, but there was no parent-child correlation for age at onset or intrasibship clustering of tremor or onset age. A suggestion of anticipation disappeared after adjustment for age-related ascertainment bias. The findings show that a presumably single mutation can produce a heterogeneous PD phenotype, even among siblings. This is consistent with the hypothesis that PD in the community may in fact be ...Continue Reading

References

Aug 1, 1991·Archives of Neurology·E GranieriP De Bastiani
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·D M MaraganoreC D Marsden
Mar 1, 1990·Annals of Neurology·L I GolbeR C Duvoisin
Oct 1, 1990·Neurology·E McCrank
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·W G JohnsonR Duvoisin
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·W PoeweM Emre
Feb 22, 1986·British Medical Journal·W J MutchS K Roy
May 26, 1988·The New England Journal of Medicine·L P Rowland
Aug 1, 1986·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·M E AlonsoH H Figueroa
Jan 1, 1986·Neurology·M C KiokS Lavine
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Jan 1, 1981·Neurology·R C DuvoisinD Calne
May 1, 1995·Annals of Neurology·P Vieregge, I Heberlein
Jan 1, 1995·Neurology·H PayamiJ Nutt
Oct 1, 1994·Neurology·V BonifatiG Meco
Dec 1, 1993·Annals of Neurology·K P BhatiaC D Marsden
Jan 1, 1994·Annals of Neurology·C H Waters, C A Miller
Jun 1, 1993·Nature Genetics·M SchallingD E Housman
Sep 1, 1993·Neurology·L I Golbe
Sep 1, 1993·Neurology·J P HubbleW C Koller
Feb 1, 1993·Archives of Neurology·A J HughesA J Lees
Nov 1, 1995·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·V BonifatiG Meco
Jan 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·G De MicheleG Campanella
Feb 3, 1962·JAMA : the Journal of the American Medical Association·G G SPELLMAN

❮ Previous
Next ❯

Citations

Sep 11, 1999·Annals of Neurology·K MarkopoulouB A Chase
Sep 29, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·S AimeL Lopiano
Apr 1, 2003·Annals of Neurology·Thomas T Warner, Anthony H V Schapira
Jun 18, 1998·Annals of Neurology·M D MuenterD B Calne
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Spiridon PapapetropoulosAglaia Athanassiadou
Dec 19, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·S BostantjopoulouA Lees
Apr 16, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·O BandmannN W Wood
Oct 2, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·J W LanceM Vidailhet
Mar 24, 2005·Journal of Neural Transmission·A Krygowska-WajsZ K Wszolek
Sep 1, 2005·Current Neurology and Neuroscience Reports·Alistair J Lewthwaite, David J Nicholl
Jun 11, 2008·Current Neurology and Neuroscience Reports·Vincenzo Bonifati
Nov 14, 2002·Neurotoxicology·J William Langston
Jun 24, 1998·Clinical Neurology and Neurosurgery·B A VeldmanM W Horstink
Jun 1, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Y MizunoH Mori
Jun 1, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A M Bonnet, J L Houeto
May 10, 2001·Parkinsonism & Related Disorders·B V. ManyamM Ghobrial
May 10, 2001·Parkinsonism & Related Disorders·A -M. KuopioU K. Rinne
Jul 27, 2001·Parkinsonism & Related Disorders·P K PalD B Calne
Mar 6, 2003·Parkinsonism & Related Disorders·Anna Krygowska-WajsZbigniew K Wszolek
Jul 2, 2008·Parkinsonism & Related Disorders·A H Rajput, S Birdi
Jul 2, 2008·Parkinsonism & Related Disorders·Z K Wszolek, K Markopoulou
Jul 10, 2003·Lancet Neurology·John HardyAndrew Singleton
Jul 28, 2009·Expert Reviews in Molecular Medicine·Thomas Gasser
Mar 17, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·R A WatkinsJ S Janowsky
Mar 28, 2008·Human Molecular Genetics·Javier Simón-Sánchez, Andrew B Singleton
Jun 27, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D GosalM Toft
Jul 19, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·S M HagueO Bandmann
Apr 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·N Wood
Aug 17, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·K DujardinA Destee
Apr 20, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·S PapapetropoulosT Papapetropoulos
Sep 18, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·T FoltynieR A Barker
Aug 22, 2006·Dementia and Geriatric Cognitive Disorders·Martin Wilhelm KurzDag Aarsland
Jul 16, 2011·International Journal of Alzheimer's Disease·Gilbert J HoMakoto Hashimoto
Jun 5, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·R DjaldettiE Melamed
Jan 9, 2003·Archives of Physiology and Biochemistry·K G UsunoffE Marani
Jul 28, 2009·Parkinsonism & Related Disorders·Andreas PuschmannChrister Nilsson
Jan 1, 2013·Intrinsically Disordered Proteins·T Reid Alderson, John L Markley
Jun 3, 2016·Journal of Neural Transmission·Nicola TambascoPaolo Calabresi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.